Introduction
CD40 is a 48-kDa transmembrane glycoprotein surface receptor also known as the tumor necrosis factor receptor superfamily member 5 (TNFRSF5). It is expressed at the cell surface of antigen-presenting cells of the hematopoietic lineage, including B cells, dendritic cells (DCs), Langerhans cells, and macrophages, and is also expressed by non-hematopoietic cells such as endothelial cells (
Hollenbaugh et al., 1995- Hollenbaugh D.
- Mischel-Petty N.
- Edwards C.P.
- et al.
Expression of functional CD40 by vascular endothelial cells.
), fibroblasts (
Fries et al., 1995- Fries K.M.
- Sempowski G.D.
- Gaspari A.A.
- et al.
CD40 expression by human fibroblasts.
;
Yellin et al., 1995- Yellin M.J.
- Winikoff S.
- Fortune S.M.
- et al.
Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation.
), smooth muscle cells, and epithelial cells (ECs) (
). The ligand for CD40 is the type II membrane protein CD40L (CD154), which is primarily expressed on activated CD4
+ T-helper cells. The CD40–CD154 interaction has a role in both cellular and humoral immune responses. Upon CD40 ligation, DCs mature and become activated to produce high levels of pro-inflammatory cytokines and chemokines, and upregulate major histocompatibility complex class II and co-stimulatory molecules such as CD80 and CD86. Together, these upregulated molecules facilitate effective priming of CD8
+ T cells and stimulate activated CD8
+ T cells to become cytotoxic effector cells (
). In B cells, CD40 ligation induces immunoglobulin isotype switching and differentiation as well as inhibits apoptosis by upregulating anti-apoptotic genes such as cIAPs, members of the BCL2 family, and MYC (
Kehry, 1996CD40-mediated signaling in B cells. Balancing cell survival, growth, and death.
;
Laman et al., 1996- Laman J.D.
- Claassen E.
- Noelle R.J.
Functions of CD40 and its ligand, gp39 (CD40L).
). Deregulation of CD40–CD154 interaction can lead to various clinical conditions (
Peters et al., 2009- Peters A.L.
- Stunz L.L.
- Bishop G.A.
CD40 and autoimmunity: the dark side of a great activator.
), such as autoimmune diseases, multiple sclerosis, allograft rejections, intraepithelial pre-malignancies, and inflammatory skin diseases such as psoriasis and subacute cutaneous lupus erythematosus (
Caproni et al., 2007- Caproni M.
- Torchia D.
- Antiga E.
- et al.
The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
).
In the epidermis, CD40 is expressed at low levels by basal and parabasal layer ECs. ECs upregulate CD40 expression when stimulated with IFNγ (
Denfeld et al., 1996- Denfeld R.W.
- Hollenbaugh D.
- Fehrenbach A.
- et al.
CD40 is functionally expressed on human keratinocytes.
;
Gaspari et al., 1996- Gaspari A.A.
- Sempowski G.D.
- Chess P.
- et al.
Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism.
;
Peguet-Navarro et al., 1997- Peguet-Navarro J.
- Dalbiez-Gauthier C.
- Moulon C.
- et al.
CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.
), which is normally produced by effector cells of the innate immune system and by activated type 1 polarized (IFNγ-producing) CD40L-expressing CD4
+ T-helper (Th1) cells that enter the skin (
Swamy et al., 2010- Swamy M.
- Jamora C.
- Havran W.
- et al.
Epithelial decision makers: in search of the “epimmunome”.
;
van den Bogaard et al., 2013- van den Bogaard E.H.
- Tjabringa G.S.
- Joosten I.
- et al.
Crosstalk between keratinocytes and T Cells in a 3D microenvironment: a model to study inflammatory skin diseases.
). Indeed, CD40 is highly expressed by ECs in T-cell–infiltrated psoriatic lesions (
Denfeld et al., 1996- Denfeld R.W.
- Hollenbaugh D.
- Fehrenbach A.
- et al.
CD40 is functionally expressed on human keratinocytes.
). A limited number of
in vitro studies on CD40 ligation of human primary IFNγ-stimulated ECs showed that these cells express ICAM-1 and secrete RANTES (CCL5), TNFα, IL-6, IL-8, and MCP-1 (CCL2) (
Denfeld et al., 1996- Denfeld R.W.
- Hollenbaugh D.
- Fehrenbach A.
- et al.
CD40 is functionally expressed on human keratinocytes.
;
Gaspari et al., 1996- Gaspari A.A.
- Sempowski G.D.
- Chess P.
- et al.
Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism.
;
Peguet-Navarro et al., 1997- Peguet-Navarro J.
- Dalbiez-Gauthier C.
- Moulon C.
- et al.
CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.
;
Companjen et al., 2002- Companjen A.R.
- van der Wel L.I.
- Boon L.
- et al.
CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1.
;
Pasch et al., 2004- Pasch M.C.
- Timar K.K.
- van Meurs M.
- et al.
In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro.
). In addition, there is evidence that CD40-activated ECs stop proliferating and start differentiating (
Peguet-Navarro et al., 1997- Peguet-Navarro J.
- Dalbiez-Gauthier C.
- Moulon C.
- et al.
CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.
;
Grousson et al., 2000- Grousson J.
- Ffrench M.
- Concha M.
- et al.
CD40 ligation alters the cell cycle of differentiating keratinocytes.
;
Concha et al., 2003- Concha M.
- Vidal M.A.
- Moreno I.
- et al.
Evidence for modulation of human epidermal differentiation and remodelling by CD40.
;
Villarroel Dorrego et al., 2006- Villarroel Dorrego M.
- Whawell S.A.
- Speight P.M.
- et al.
Transfection and ligation of CD40 in human oral keratinocytes affect proliferation, adhesion and migration but not apoptosis in vitro.
). However, the full spectrum of effects mediated by CD40 ligation on the response of ECs is still unknown.
The basal and parabasal layer ECs of squamous epithelia are a well-known target for different viruses (
Andrei et al., 2010- Andrei G.
- Duraffour S.
- Van den Oord J.
- et al.
Epithelial raft cultures for investigations of virus growth, pathogenesis and efficacy of antiviral agents.
), including high-risk human papilloma virus (hrHPV). Chronic infections with hrHPV can last for many years, probably as a result of several sophisticated mechanisms employed by hrHPV to evade the hosts’ innate immune response (
Karim et al., 2011- Karim R.
- Meyers C.
- Backendorf C.
- et al.
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.
;
Reiser et al., 2011- Reiser J.
- Hurst J.
- Voges M.
- et al.
High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.
;
Karim et al., 2013- Karim R.
- Tummers B.
- Meyers C.
- et al.
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte’s innate immune response.
). Interestingly, an
in vivo model for EC-specific human-CD40 expression and activation showed that CD40 ligation on ECs enhanced DC migration and T-cell priming in a mouse model (
Fuller et al., 2002- Fuller B.W.
- Nishimura T.
- Noelle R.J.
The selective triggering of CD40 on keratinocytes in vivo enhances cell-mediated immunity.
), suggesting that ECs boost the activity of cells from the adaptive immune system. HPV-specific cellular immunity, however, develops quite late and slowly during persistent HPV infections (
), posing the question whether HPV may also impair pathways typically associated with activation of the adaptive immune response.
To obtain a better understanding of the outcome between the interaction of ECs and CD40 ligand–expressing CD4+ Th1 cells, we analyzed the genome-wide expression profiles of CD40-stimulated undifferentiated primary ECs. We observed that ECs react in a very coordinated manner to CD40 ligation with the induction of mainly immune-related genes and the attraction of immune cells. The parallel analysis of hrHPV-infected primary ECs revealed that hrHPV did not grossly change the gene expression pattern but attenuated the magnitude of the CD40-stimulated immune response, resulting in an impaired immune cell attraction. These data strengthen the notion that the CD40–CD154 pathway has an important role in protective epithelial immune responses.
Discussion
We studied the response of ECs to CD40 ligation, a major immune trigger of B- and T-cell immunity and a major cue for leukocyte migration toward the skin. Stimulation of ECs via CD40 resulted in a highly coordinated regulation of predominantly immune-related genes involved in the attraction, sustainment, and amplification of adaptive immune responses as well as resulted in the attraction of immune cells. Interestingly, hrHPV infection did not qualitatively alter the gene expression profile of CD40-stimulated ECs; instead, the extent of the response was attenuated. The fact that HPV attenuates CD40 signaling in ECs indicates the importance of the CD40–CD154 immune pathway in boosting immunity in epithelia.
Microarray expression studies showed that CD40 ligation of non-hematopoietic cells, such as endothelial cells (
Pluvinet et al., 2008- Pluvinet R.
- Olivar R.
- Krupinski J.
- et al.
CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling.
), pancreatic cells (
Klein et al., 2008- Klein D.
- Timoneri F.
- Ichii H.
- et al.
CD40 activation in human pancreatic islets and ductal cells.
), renal proximal tubule ECs (
Li and Nord, 2005CD40/CD154 ligation induces mononuclear cell adhesion to human renal proximal tubule cells via increased ICAM-1 expression.
), smooth muscle cells (
Stojakovic et al., 2007- Stojakovic M.
- Krzesz R.
- Wagner A.H.
- et al.
CD154-stimulated GM-CSF release by vascular smooth muscle cells elicits monocyte activation—role in atherogenesis.
), microglia (
Ait-Ghezala et al., 2005- Ait-Ghezala G.
- Mathura V.S.
- Laporte V.
- et al.
Genomic regulation after CD40 stimulation in microglia: relevance to Alzheimer’s disease.
), and ECs (this report), generally results in the upregulation of genes involved in immunity and inflammatory responses, cell fate, and cell adhesion. The response of ECs to CD40 stimulation is alike that of muscle cells and pancreatic cells. Endothelial cells seem to have a broader response as they also upregulate genes involved in the viral immune surveillance system, e.g., the 2′-5′-oligoadenylate/RNase L system and guanylate-binding proteins (GBP1–4), potentially to keep the vasculature from harmful consequences and prevent the spread of systemic viral infection in the host (
Pluvinet et al., 2008- Pluvinet R.
- Olivar R.
- Krupinski J.
- et al.
CD40: an upstream master switch for endothelial cell activation uncovered by RNAi-coupled transcriptional profiling.
). ECs are well equipped with viral sensors, which can launch an antiviral response upon infection (
Karim et al., 2011- Karim R.
- Meyers C.
- Backendorf C.
- et al.
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.
), and the CD40 pathway may help to establish efficient adaptive B- and T-cell immunity to expand the precision of protection after the initial innate immune cell response.
Interestingly, we found that late CD40-mediated responses in ECs involved the upregulation of the anti-apoptosis genes
cIAP2 and
BCL3 as well as the negative regulator of proliferation
RARRES1. These observations may explain earlier findings that ECs do not go into apoptosis but rather stop proliferating after CD40 ligation (
Peguet-Navarro et al., 1997- Peguet-Navarro J.
- Dalbiez-Gauthier C.
- Moulon C.
- et al.
CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.
). We are currently exploring this further. The response of ECs to CD40 stimulation is paralleled by B cells, which respond to CD40 ligation by preventing apoptosis through the upregulation of several anti-apoptotic genes, including
cIAPs,
MYC, and
BCL2 members (
Kehry, 1996CD40-mediated signaling in B cells. Balancing cell survival, growth, and death.
;
Laman et al., 1996- Laman J.D.
- Claassen E.
- Noelle R.J.
Functions of CD40 and its ligand, gp39 (CD40L).
).
CD40 stimulation of DCs has been thoroughly studied as it has a key role in the activation, maturation, and T-cell priming capacity of DCs. Upon CD40 stimulation, DCs produce pro-inflammatory cytokines and chemokines, upregulate human leukocyte antigen class I and II as well as the co-stimulatory molecules CD86 and CD80 (
). This allows DCs to convey the appropriate signals to T cells required for them to become effector cells. Candidate gene studies showed that ECs can express CD40, human leukocyte antigen class I and II, CD86 but not CD80 (
Black et al., 2007- Black A.P.
- Ardern-Jones M.R.
- Kasprowicz V.
- et al.
Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.
;
Ortiz-Sanchez et al., 2007- Ortiz-Sanchez E.
- Chavez-Olmos P.
- Pina-Sanchez P.
- et al.
Expression of the costimulatory molecule CD86, but not CD80, in keratinocytes of normal cervical epithelium and human papillomavirus-16 positive low squamous intraepithelial lesions.
;
Romero-Tlalolini et al., 2013- Romero-Tlalolini M.A.
- Chavez Olmos P.
- Garrido E.
Differential DNA methylation patterns in the CD86 gene controls its constitutive expression in keratinocytes.
), as well as the co-stimulatory molecules CD83 and ICAM-1 and a number of cytokines after being exposed to IFNγ and CD40 activation (
Denfeld et al., 1996- Denfeld R.W.
- Hollenbaugh D.
- Fehrenbach A.
- et al.
CD40 is functionally expressed on human keratinocytes.
;
Gaspari et al., 1996- Gaspari A.A.
- Sempowski G.D.
- Chess P.
- et al.
Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism.
;
Peguet-Navarro et al., 1997- Peguet-Navarro J.
- Dalbiez-Gauthier C.
- Moulon C.
- et al.
CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.
;
Companjen et al., 2002- Companjen A.R.
- van der Wel L.I.
- Boon L.
- et al.
CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1.
;
Pasch et al., 2004- Pasch M.C.
- Timar K.K.
- van Meurs M.
- et al.
In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro.
). This may allow CD40-stimulated ECs to process and present antigen to effector/memory CD4
+ and CD8
+ T cells (
Black et al., 2007- Black A.P.
- Ardern-Jones M.R.
- Kasprowicz V.
- et al.
Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.
) as well as to amplify immune responses. However, it is not likely that such activated ECs function as professional antigen-processing cells as it was shown that CD40L-activated ECs fail to prime allogeneic T-cell reactions, underlining the difference of CD40 ligation on professional and nonprofessional antigen-processing cells (
Grousson et al., 2000- Grousson J.
- Ffrench M.
- Concha M.
- et al.
CD40 ligation alters the cell cycle of differentiating keratinocytes.
).
The pathogenesis of skin diseases such as psoriasis is based on an influx of immune cells into psoriatic lesions where cytokine levels are elevated. Our results sustain the notion that tissue-infiltrating T cells may exacerbate the disease via the production of IFNγ and the interaction with CD40 on ECs. The resulting cytokines may amplify the immune response via the attraction of more immune cells, thereby forming a loop in EC stimulation and cytokine production. The involvement of ECs in the exacerbation of disease has been questioned, as CD40 expression on ECs
in vivo can be weak (
). However, we and others have shown that CD40 expression is rapidly upregulated (at least temporarily) under the influence of physiological doses of IFNγ, and thus weak steady-state expression does not preclude robust action under conditions of immune activation.
HPV attenuates the extent of the ECs’ response to CD40 ligation, suggesting that HPV interferes with CD40 ligation–induced signal transduction and subsequent canonical and noncanonical NFκB activation (
;
;
). Several research groups have reported that hrHPV deregulates NFκB activation following the activation of pattern recognition receptors (PRRs) (
Karim et al., 2011- Karim R.
- Meyers C.
- Backendorf C.
- et al.
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.
;
Reiser et al., 2011- Reiser J.
- Hurst J.
- Voges M.
- et al.
High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.
) or the TNF receptor (
Termini et al., 2008- Termini L.
- Boccardo E.
- Esteves G.H.
- et al.
Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment.
). We and others have previously shown that hrHPV attenuates the pattern recognition receptor-induced (
Karim et al., 2013- Karim R.
- Tummers B.
- Meyers C.
- et al.
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte’s innate immune response.
) and TNFR-induced (
Takami et al., 2007- Takami Y.
- Nakagami H.
- Morishita R.
- et al.
Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
) NFκB pathway activation by upregulating UCHL1, a cellular deubiquitinase/E3 ligase. Therefore, the expression of UCHL1, or other non-identified modulators, may explain how HPV mediates the attenuation of CD40 ligation–induced gene expression.
Surprisingly, PBMCs were more attracted to supernatants of non-CD40-ligated HPV-positive ECs than to uninfected ECs, implying that supernatants of HPV-positive ECs contain higher cytokine levels compared with supernatants of uninfected ECs. However, not only in this study but also in previous studies (
Karim et al., 2011- Karim R.
- Meyers C.
- Backendorf C.
- et al.
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.
;
Karim et al., 2013- Karim R.
- Tummers B.
- Meyers C.
- et al.
Human papillomavirus (HPV) upregulates the cellular deubiquitinase UCHL1 to suppress the keratinocyte’s innate immune response.
) we observed that hrHPV generally downregulates the basal expression and secretion of many pro-inflammatory cytokines. Recent literature has shown that metabolism intermediates can act as inflammatory signals (
Tannahill et al., 2013- Tannahill G.M.
- Curtis A.M.
- Adamik J.
- et al.
Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha.
), implying that a simple difference in cell density can affect basal immune cell attraction. Although both the HPV-positive and uninfected ECs have been treated exactly the same throughout the experiments, HPV-positive ECs proliferate faster than uninfected ECs, and as such the supernatants may contain higher metabolite levels to mediate CD40-independent PBMC attraction toward HPV-positive cells. In HPV-positive ECs, despite the higher basal numbers of attracted PBMCs, CD40 stimulation does not result in an increased number of PBMCs attracted, whereas in uninfected ECs this is the case.
In conclusion, epithelial cells show a coordinated response to CD40 ligation, mainly inducing the expression of genes involved in leukocyte migration, cell-to-cell signaling and interaction, as well as cell death and survival. HPV attenuates the extent of CD40 signaling, resulting in lower amounts of chemoattractants produced and a failure to enhance immune cell migration. These data suggest that progression of inflammatory skin diseases may be driven by highly programmed immune activation scenarios in ECs, which have their evolutionary basis in the ECs’ response to infections.
Materials and Methods
Ethics statement
The use of discarded human foreskin, cervical, and vaginal keratinocyte tissues to develop cell lines for these studies was approved by the Institutional Review Board at the Pennsylvania State University College of Medicine and by the Institutional Review Board at Pinnacle Health Hospitals. The Medical Ethical Committee of the Leiden University Medical Center approved the human tissue sections (healthy foreskin, healthy cervix, HPV16- or 18-positive cervical neoplasias) used for staining. All sections and cell lines were derived from discarded tissues and de-identified; therefore, no informed consent was necessary.
Cell culture
Primary cultures of human ECs were established from foreskin, vaginal, and cervical tissues as previously described (
Karim et al., 2011- Karim R.
- Meyers C.
- Backendorf C.
- et al.
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes.
) and grown in keratinocyte serum-free medium (K-SFM; Medium 154 supplemented with HKGS kit, Invitrogen, Breda, The Netherlands). The cells morphologically and biochemically resembled ECs in both monolayer and organotypic raft cultures, as indicated by keratin expression, hemidesmosome, and desmosome structures, and in their ability to differentiate into full-thickness epithelium (
Meyers et al., 1997- Meyers C.
- Mayer T.J.
- Ozbun M.A.
Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.
;
). By using the microarray data, the cells were verified to express high levels of keratin (KRT) 10, 14, 17, and 19, and low levels of KRT18 (
Supplementary Figure S5 online), a signature specific for keratinocytes (
Moll et al., 2008- Moll R.
- Divo M.
- Langbein L.
The human keratins: biology and pathology.
;
Bononi et al., 2012- Bononi I.
- Bosi S.
- Bonaccorsi G.
- et al.
Establishment of keratinocyte colonies from small-sized cervical intraepithelial neoplasia specimens.
). EC lines stably maintaining the full episomal HPV genome following electroporation (HPV-positive ECs) were grown in a monolayer culture using E medium in the presence of mitomycin C–treated J2 3T3 feeder cells (
Meyers et al., 1997- Meyers C.
- Mayer T.J.
- Ozbun M.A.
Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.
;
) for two passages and were then adapted to K-SFM for one passage before experimentation. Because primary ECs have a limited life span and do not survive long enough to undergo a mock electroporation procedure similar to that used to obtain HPV-positive ECs, normal undifferentiated primary ECs were used as control. J2 3T3 mouse fibroblasts and L cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 8% fetal bovine serum, 2 m
M l-glutamine, and 1% penicillin–streptomycin (complete Dulbecco’s modified Eagle’s medium) (Gibco-BRL, Invitrogen).
CD40 ligation on ECs
Uninfected ECs or HPV-positive ECs were seeded at 1.5 × 105 cells per well in six-well plates in K-SFM and allowed to attach for 24 hours, after which the cells received fresh K-SFM containing 50 IU ml-1 IFNγ (Immunotools, Friesoythe, Germany) for 72 hours. Control or CD40L-expressing L cells were harvested, irradiated (4,800–5,200 rad), and resuspended in K-SFM containing 50 IU ml-1 IFNγ. L cells were cocultured with ECs in a 1:1 ratio for indicated time points, after which the supernatant was collected, the L cells were removed, and the RNA of the ECs was harvested. CD40L expression and functionality of the L cells were validated, as was the percentage of residual L cells after coculture (<1%; data not shown).
RNA expression analyses and ELISA
Total RNA was isolated using the NucleoSpin RNA II kit (Machery-Nagel, Leiden, The Netherlands) according to the manufacturer’s instructions. Total RNA (0.5–1.0 μg) was reverse transcribed using the SuperScript III First Strand synthesis system from Invitrogen. TaqMan PCR was performed using TaqMan Universal PCR Master Mix and pre-designed, pre-optimized primers and probe mix for RANTES (CCL5), IL8, and GAPDH (Applied Biosystems, Foster City). Threshold cycle numbers (Ct) were determined using the CFX PCR System (Bio-Rad, Veenendaal, The Netherlands), and the relative quantities of complementary DNA per sample were calculated using the ΔΔCt method using GAPDH as the calibrator gene. ELISA’s for CCL2, RANTES, IL8, and CXCL10 were performed according to the manufacturer’s instructions (PeproTech, London, UK). Statistical differences in cytokine production were evaluated using a Welch-corrected t-test, correcting for possible unequal variances between the groups.
Gene expression profiling
Four primary EC cultures were used, HVK (vaginal), HCK (cervical), HFK_1, and HFK_2 (both foreskin), as well as four EC cell lines stably maintaining episomal HPV16 or 18, HVK16 (vaginal), HVK18 (vaginal), HCK18 (cervical), and HPV16 (foreskin). Cells were harvested at five conditions: 0, 2 and, 24 hours of 50 IU ml
-1 IFNγ in combination with either L-control or L-CD40L cells. Stimulated 2- and 24-hour samples were generated
in duplo. Total RNA for these 72 samples was isolated as stated above. The microarray experiment was performed by ServiceXS according to their protocols (ServiceXS, Leiden, The Netherlands). Briefly, total RNA was analyzed by Lab-on-a-Chip. All RNA showed a RNA integrity number score of >9.5. Total RNA was reverse-transcribed, amplified, and biotin labeled. cRNA was hybridized to Illumina (San Diego, CA) Human HT-12 v4 BeadChips in a randomized manner and scanned with the Illumina iScan. Samples passed quality control as assessed by Illumina GenomeStudio software. Values for missing bead types on the HumanHT-12 BeadChip were estimated using the k-Nearest Neighbor (k-NN) algorithm (
Troyanskaya et al., 2001- Troyanskaya O.
- Cantor M.
- Sherlock G.
- et al.
Missing value estimation methods for DNA microarrays.
) in Illumina’s BeadStudio Gene Expression Module (v3.3+).
Microarray data preprocessing
The expression array data were analyzed using R2.14.1 and Bioconductor (
). The data were normalized using the Bioconductor package lumi version 2.6.0 (
Du et al., 2008- Du P.
- Kibbe W.A.
- Lin S.M.
lumi: a pipeline for processing Illumina microarray.
;
Lin et al., 2008- Lin S.M.
- Du P.
- Huber W.
- et al.
Model-based variance-stabilizing transformation for Illumina microarray data.
), resulting in log2-transformed normalized intensities. Quality control plots were generated using limma version 3.10.2 (
) and mpm version 1.0–22 (
Wouters et al., 2003- Wouters L.
- Gohlmann H.W.
- Bijnens L.
- et al.
Graphical exploration of gene expression data: a comparative study of three multivariate methods.
;
Wouters, 2011Exploratory graphical analysis of multivariate data, specifically gene expression data with different projection methods: principal component analysis, correspondence analysis, spectral map analysis.
). Uninfected and HPV-positive ECs correlated in separate blocks, and within these blocks the next level similarity was at the cell line level, and within cell line at the exposure level, indicating that the data behaved as expected (data not shown). All microarray data are MIAME compliant and the raw data have been deposited in the MIAME compliant database Gene Expression Omnibus with accession number GSE54181, as detailed on the MGED Society website
http://www.mged.org/Workgroups/MIAME/miame.html.
Analysis of differentially gene expression
Differentially expressed genes were identified using maanova version 1.24.0 (
;
Wu et al., 2003- Wu H.
- Kerr M.K.
- Cui X.Q.
- et al.
MAANOVA: a software package for the analysis of spotted cDNA microarray experiments.
). We modeled the cell line effect as a random effect and indicated the technical replicates in the model. We calculated test statistics for testing the null hypotheses of no difference in expression between L-CD40L-stimulated and L-control-stimulated cells at 2 and 24 hours for uninfected ECs as well as HPV-positive ECs for each gene. We applied the Fs statistic, which uses a shrinkage estimator for gene-specific variance components based on the James–Stein estimator. To correct for multiple testing, false discovery rates were calculated using the q-value method (
Dabneyqvalue: Q-value estimation for false discovery rate control.
;
). The ranking and selection of the genes are based on these adjusted
P-values.
Functional genomics analyses
The networks were constructed using Ingenuity Pathway Analysis (IPA version 17199142; Ingenuity systems,
www.ingenuity.com). The list of differentially expressed genes was used to generate the network. All edges are supported by at least one reference from the literature, from a textbook, or from canonical information stored in the Ingenuity Pathway Knowledge Base.
Box plot representations
Boxplots are drawn as a box, containing the 1st quartile up to the 3rd quartile of the data values. The median is represented as a line within the box. Whiskers represent the values of the outer two quartiles. These whiskers are, however, maximized at 1.5 times the size of the box (also known as inter-quartile distance). If one or more values outside of the whiskers are present, then this is indicated with a single mark “o” next to the implicated whisker. Plots were generated using the webtool R2: microarray analysis and visualization platform (
http://r2.amc.nl).
Migration assays
IFNγ pre-stimulated (HPV-positive) ECs were cocultured with L cells for 3 hours, after which the L cells were removed. The ECs were cultured for a subsequent 24 hours with fresh K-SFM. Cleared (HPV-positive) EC supernatants were added to the lower compartment of a trans-well plate (Corning). The upper compartment was filled with PBMCs, which were allowed to migrate for 16 hours, after which the cells in the lower compartment were counted by flow cytometry in the presence of counting beads (Invitrogen) according to the manufacturer’s protocol. Myeloid cells and lymphocytes were differentiated by their respective size in the forward scatter/side scatter plot (data not shown). To normalize for biological differences between PBMC donors and EC cultures, a migration index was calculated of the total number of PBMCs migrated toward the indicated stimulation over the medium control. The statistical significance of differences in migration toward supernatants of EC cultures stimulated with CD40L or control L cells was assessed using a paired t-test.
Flow cytometry
Expression of CD40 on ECs was analyzed by flow cytometry using FITC-coupled mouse anti-human CD40 antibodies (BD Biosciences, Breda, The Netherlands). A total of 50,000 cells per live gate were recorded using the BD FACS Calibur with Cellquest software (BD Bioscience) and data were analyzed using Flowjo (Treestar, Olten, Switzerland).
Article info
Publication history
Accepted:
May 20,
2014
Received in revised form:
May 19,
2014
Received:
January 15,
2014
accepted article preview online 19 June 2014 published online 14 August 2014
Footnotes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
CM has received speaker honoraria from Merck, Quest Diagnostics, GSK, and Bristol-Myers. CM has performed research funded by Merck, The Phillip Morris External Research Program, NexMed, GSK, OriGenix, and Interferon Sciences Inc. The remaining authors state no conflict of interest.
Copyright
© 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc.